Prostate cancer outcomes study. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Prostate Cell Line, Tumor Tumor Cells, Cultured

Organisms1

Diseases15

Prostatic Neoplasms Breast Neoplasms Neoplasms Prostatic Hyperplasia Disease Progression Adenocarcinoma Neoplasms, Hormone-Dependent Neoplasm Recurrence, Local Neoplasm Metastasis Prostatic Intraepithelial Neoplasia Bone Neoplasms Neoplasm Invasiveness Lung Neoplasms Genetic Predisposition to Disease Urinary Bladder Neoplasms

Chemicals and Drugs14

Prostate-Specific Antigen Receptors, Androgen Androgens Androgen Antagonists Tumor Markers, Biological Tosyl Compounds Antineoplastic Agents Antineoplastic Agents, Hormonal Neoplasm Proteins Androgen Receptor Antagonists Anilides RNA, Messenger Dihydrotestosterone Finasteride

Analytical, Diagnostic and Therapeutic Techniques and Equipment45

Prostatectomy Treatment Outcome Prognosis Neoplasm Staging Follow-Up Studies Early Detection of Cancer Prospective Studies Risk Factors Cohort Studies Retrospective Studies Survival Analysis Orchiectomy SEER Program Survival Rate Questionnaires Risk Assessment Kaplan-Meier Estimate Gene Expression Profiling Registries Predictive Value of Tests Proportional Hazards Models Case-Control Studies Reproducibility of Results Multivariate Analysis Incidence Disease-Free Survival Neoplasm Grading Logistic Models Clinical Trials as Topic Reverse Transcriptase Polymerase Chain Reaction Radiotherapy Oligonucleotide Array Sequence Analysis Xenograft Model Antitumor Assays Digital Rectal Examination Chemotherapy, Adjuvant Sensitivity and Specificity Neoplasm Transplantation Molteno Implants Immunohistochemistry Mass Screening Transplantation, Heterologous Randomized Controlled Trials as Topic Odds Ratio Risk Severity of Illness Index

Phenomena and Processes8

Gene Expression Regulation, Neoplastic Time Factors Cell Proliferation Genetic Predisposition to Disease Apoptosis Sensitivity and Specificity Odds Ratio Risk

Disciplines and Occupations2

Outcome Assessment (Health Care)Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena3

Quality of Life Health Status Socioeconomic Factors

Humanities1

Quality of Life

Information Science5

SEER Program Survival Rate Questionnaires Registries Incidence

Named Groups2

African Americans European Continental Ancestry Group

Health Care33

Treatment Outcome Outcome Assessment (Health Care)Follow-Up Studies Prospective Studies Risk Factors Cohort Studies Retrospective Studies Survival Analysis SEER Program Survival Rate Questionnaires Risk Assessment Kaplan-Meier Estimate Registries Predictive Value of Tests Proportional Hazards Models Case-Control Studies Reproducibility of Results Multivariate Analysis Incidence Disease-Free Survival Logistic Models Clinical Trials as Topic Age Factors Health Status Watchful Waiting Sensitivity and Specificity Mass Screening Randomized Controlled Trials as Topic Odds Ratio Risk Severity of Illness Index Socioeconomic Factors

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Prostatic Neoplasms Prostatectomy Prostate-Specific Antigen Treatment Outcome Prostate Breast Neoplasms Prognosis Outcome Assessment (Health Care)Receptors, Androgen Androgens Quality of Life Cell Line, Tumor Androgen Antagonists Gene Expression Regulation, Neoplastic Neoplasm Staging Follow-Up Studies Tumor Markers, Biological Early Detection of Cancer Neoplasms Prospective Studies Risk Factors United States Prostatic Hyperplasia Cohort Studies Disease Progression Retrospective Studies Survival Analysis Orchiectomy Adenocarcinoma Neoplasms, Hormone-Dependent SEER Program Survival Rate Time Factors Neoplasm Recurrence, Local Questionnaires Risk Assessment Neoplasm Metastasis Mice, Nude Kaplan-Meier Estimate African Americans Gene Expression Profiling Registries Prostatic Intraepithelial Neoplasia Predictive Value of Tests Proportional Hazards Models European Continental Ancestry Group Case-Control Studies Reproducibility of Results Multivariate Analysis Tosyl Compounds Bone Neoplasms Neoplasm Invasiveness Incidence Disease-Free Survival Neoplasm Grading Logistic Models Cell Proliferation Antineoplastic Agents Lung Neoplasms Antineoplastic Agents, Hormonal Genetic Predisposition to Disease Apoptosis Tumor Cells, Cultured Clinical Trials as Topic Neoplasm Proteins Androgen Receptor Antagonists Reverse Transcriptase Polymerase Chain Reaction Radiotherapy Oligonucleotide Array Sequence Analysis Xenograft Model Antitumor Assays Digital Rectal Examination Age Factors Anilides Health Status Chemotherapy, Adjuvant Watchful Waiting RNA, Messenger Urinary Bladder Neoplasms Sensitivity and Specificity Neoplasm Transplantation Dihydrotestosterone Molteno Implants Immunohistochemistry Mass Screening Finasteride Transplantation, Heterologous Randomized Controlled Trials as Topic Odds Ratio Risk Severity of Illness Index Socioeconomic Factors

No FAQ available that match "prostate cancer outcomes study"